Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...

Groundbreaking research shows that as men age, harmful genetic mutations in sperm become more common—not just from random ...

In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...

In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.

Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy with back-to-back review articles published in ...

DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible plate-based ...

Cleared by the FDA in 2024, the test gained real-world traction in 2025 when it was incorporated into a new global framework ...

A groundbreaking new study has found that a 'next-generation' cancer vaccine has not only cleared existing tumors but could ...